<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges</h1>
  <ul>
<li>
<ul>
<li>Customers postponed purchases of its products and services this cycle as its revenue declined by 1.2% annually over the last two years - Smaller revenue base of $2.31 billion means it hasn’t achieved the economies of s</li>
</ul>
</li>
<li>
<ul>
<li>Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&amp;A to catalyze faster growth - Competitive supply chain dynamics and steep production costs are</li>
</ul>
</li>
<li>
<ul>
<li>Annual revenue growth of 22.6% over the past two years was outstanding, reflecting market share gains this cycle - Performance over the past five years shows its incremental sales were more profitable, as its annual ea</li>
</ul>
</li>
<li>Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.</li>
<li>Two Mid-Cap Stocks to Sell: Ball (BALL) Market Cap: $13.86 billion Started with a $200 loan in 1880, Ball (NYSE:BLL) manufactures aluminum packaging for beverages, personal care, and household products as well as aerospa</li>
<li>Royalty Pharma (RPRX) Market Cap: $15.59 billion Pioneering a unique business model in the pharmaceutical industry since 1996, Royalty Pharma (NASDAQ:RPRX) acquires rights to receive portions of sales from successful bio</li>
<li>One Mid-Cap Stock to Buy: LPL Financial (LPLA) Market Cap: $26.64 billion As the nation's largest independent broker-dealer with no proprietary products of its own, LPL Financial (NASDAQ:LPLA) provides technology, compli</li>
</ul>
<p><a href="https://finance.yahoo.com/news/1-mid-cap-stock-exciting-043536297.html">Source</a> · 2025-09-08T04:35:36+00:00</p>
</body>
</html>